Environmental exposure and hemorrhage are the primary contributing factors to the onset of hypothermia in soldiers injured on the battlefield. While several strategies including wool blankets, electric blankets, and forced air coverlets are currently available for use in casualty patient care, none of these provides the combination of efficiency and amenability to field deployment required to meet the current needs of the US Navy. In this Phase II Small Business Technology Transfer (STTR) program, Infoscitex Corporation (IST) and George Washington University Medical Center (GWUMC) propose the development of a novel Casualty Patient Warming Device (CPWD) that will address all the deficiencies of current technologies and provide the US Navy and other branches of the Department of Defense with a high efficiency, safe, low cost, rugged, versatile, and field-deployable method for preventing the onset of hypothermia in casualty patients. The Phase II effort will focus on prototype fabrication, design down-selection, and the first level of clinical trials to establish efficacy.
Keywords: Hemorrhage, Hypothermia, Hypothermia Prevention, Patient Warming, Military Medical Technology, Casua